Clinical Trial Update: A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa [Phase 3]

View source ↗

Summary

A Phase 3 trial in previously untreated extensive-stage small cell lung cancer compares platinum plus etoposide chemotherapy with or without darbepoetin alfa an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Etoposide (Etoposide)
• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED